We have described recently a panel of metastasisassociated antigens expressed on a rat pancreatic tumor. One of these molecules, recognized by the monoclonal antibody C4.4 and named accordingly C4.4A, was under physiological conditions expressed only in the gravid uterus and on epithelial of the upper gastrointestinal tract. The cDNA of the antigen has been isolated and cloned. The 1,637 b cDNA codes for a 352 amino acid long glycosylphosphatidyl-inositol (GP) anchored molecule, whose molecular weight varies in dierent cells between 94 ± 98 kD according to the degree of N-and Oglycosylation. Data base searches have revealed a low degree of homology to the receptor for the plasminogen activator (uPAR). After intrafootpad and intravenous application of C4.4A transfected and mocktransfected tumor cells, an increased number of lung nodules was detected with the former, whereby the individual metastatic nodules amalgamated without any encapsulation of the tumor tissue. Furthermore, C4.4A is involved in adhesion to laminin and, although transfection of a non-metastasizing tumor line with the molecule was not sucient, constitutively C4.4A-positive tumor cells penetrated through matrigel. This process could be completely prevented by C4.4. Finally, we could demonstrate that uPA, albeit weakly, bound to the C4.4A molecule. In view of the observed in¯uence of C4.4A on metastasis formation and matrix penetration it is tempting to speculate that this newly described metastasis-associated molecule may exert functional activity similar to the uPAR, i.e. via activation of matrix degrading enzymes. By the very restricted expression of the molecule in the adult organism, modulation of C4.4A could well be of therapeutic interest.
Introduction
Tumor progression is a complex process, which involves detachment from the primary tumor, migration through the extracellular matrix, penetration through the basal membrane, adaptation to the circulation pressure, attachment to the endothelia of the vessel wall and settlement and growth in distant organs (Fidler and Radinsky, 1990; Mareel et al., 1991) . According to these distinct requirements, metastatic cells frequently display on a whole array of qualitatively or quantitatively altered gene products (Bishop, 1991; Mareel et al., 1993) . These include, as the most frequent ones, cell-cell and cell-matrix adhesion molecules (Stetler-Stevenson et al., 1993; Lester and McCarthy, 1992; Evans, 1992; Behrens, 1993; Glinsky, 1993; Zetter, 1993) as well as matrixdegrading enzymes, their activators, inhibitors and receptors (Matrisian, 1992; Mignatti et al., 1986; Ossowski, 1992; DeClerck and Laug, 1993; Tryggvason, 1989; Liotta et al., 1983) . Furthermore, it has long been hypothesized and meanwhile supported by experimental evidences that the complex process of tumor progression is pursuit by master or regulatory gene products (rev. in Mareel et al., 1993) which initiate the performance of a cellular program. Those programs are by no means supposed to be tumorspeci®c, rather the metastasizing tumor cell adapts or reactivates expression of regulatory gene products used during embryogenesis, organogenesis, stem cell differentiation and lymphocyte activation, to name the most frequent programmatic changes of the physiology of multicellular organisms (Mareel et al., 1993; Glinsky, 1993; DeClerck and Laug, 1993; ZoÈ ller, 1996) .
We have described recently that a subline of a pancreatic adenocarcinoma of the rat, which metastasizes via the lymphatic system (Matzku et al., 1983) expresses a variety of surface molecules, which are also expressed on non-related, metastasizing tumor cells, but never on non-metastasizing tumors (Matzku et al., 1989; Claas et al., 1996) . Despite this restriction to the metastatic phenotype, all of these molecules were detected under physiological conditions, whereby the expression pattern varied between widespread distribution and restriction to few selected tissue layers. All of these molecules were expressed or upregulated during implantation and placentation. Some, though not all, were dierentially expressed during organogenesis (Claas et al., 1996) . One of these molecules has been identi®ed as a variant isoform of the adhesion molecule CD44 (GuÈ nthert et al., 1991) . The cDNA of three addition molecules meanwhile has been cloned: D6.1A is a tetraspanin molecule and the homologue of the human tumor antigen CO-029 (Claas et al., 1998) . The molecule is widely expressed and there is evidence that its metastasis-associated function are brought about by its linkage to additional surface structures, particularly integrins (Hemler et al., 1996; Maecker et al., 1997; Jones et al., 1996) . A molecule, named D5.7A, is the homologue to the human panepithelial antigen EGP314 (Bergsagel et al., 1992) , whose function in tumor progression is currently under investigation (Wuerfel et al., in prep.) . Here we report on the cloning and characterization of a molecule, C4.4A, which appears to facilitate the embedding of metastasizing cells by degradation of the extracellular matrix. According to a partial sequence homology to uPAR (Roldan et al., 1990; Solberg et al., 1992) and, more importantly, by its functional features, this newly described phosphatidyl-inositol anchored molecule could tentatively be grouped into the family of receptors for activators of matrix degrading enzymes. Finally, by the very restricted expression pro®le of C4.4A in the adult organism the molecule oers itself for therapeutic interference with the metastatic process.
Results
The C4.4A molecule has originally been described to be expressed by three rat tumors, BSp73ASML, RG and PROG, known to metastasize via the lymphatic system, but not by non-metastasizing rat tumor lines. A search for physiological expression of the molecule revealed that it was strongly upregulated during implantation of the blastocyst. In the adult rat, C4.4A was only detected on the basal epithelial layer of the upper gastrointestinal tract and the epidermis. Lymphoid cells did not stain with C4.4, but monocytes expressed the antigen. The same pattern of expression was noted during embryogenesis, expression of C4.4A being not observed before the last trimester (Claas et al., 1996) . By the restricted expression in the adult rat, the upregulation during implantation and the reactivation exclusively on metastasizing tumor lines, the molecule appeared of potential interest as a target for screening or as a therapeutic entity in tumor progression.
Cloning of the C4.4A cDNA COS-7 cells were repeatedly transfected with plasmid DNA of a cDNA library derived from the metastatic rat colon carcinoma line RG. C4.4A positive cells were selected by¯uorescence staining and FACS sorting (Figure 1 ). After the three Hirt extraction procedure, 12 bacterial colonies were selected and cDNA of the individual colonies was transfected into COS-7 cells. One clone was isolated which gave positive FACS staining with C4.4 mAB (data not shown). Western blot analysis con®rmed that the cells expressed a C4.4-reactive molecule of an estimated molecular weight of 94 kD, corresponding to the molecule expressed on RG, where the cDNA library was derived from. The C4.4A molecule of the metastatic ASML line had a slightly higher molecular weight.
Sequencing of the C4.4A cDNA revealed a 1637b long DNA with an open reading frame of 352 AA starting with the 5' ATG¯anked by a sequence ACAGCTATGG similar to the consensus sequence GCC(A/G)CCATGG characteristic for translation initiation sites (Kozak, 1986) . The 5' untranslated region spans 80 nucleotides. Within the 500 bases of the 3' untranslated region there is a consensus sequences for poly(A) + addition (Figure 3 ). The full length nucleotide sequence of the C4.4A revealed no strong homology to any known rat, mouse or human gene. However, there was a low level homology to the uPAR of several species .
The C4.4A molecule potentially spans 352 AA ( Figure  4 ). The molecule has consensus sequences for seven potential N-glycosylation sites. Like the uPAR, it can be divided into three domains, where domain 1 and 2 show some homology to the uPAR of several species (shown for the murine uPAR, Figure 4B ), while the third domain is unrelated. According to the AA sequence the C4.4A molecule has an isoelectric point of pH 7.04 and a theoretical M r of 36.96 kD. Western blotting under non-reducing conditions revealed molecular weights of 98 kD (ASML) and 94 kD (PROG, AS-1B1, AS-2A2) ( Figure 5 ). To determine whether the higher molecular weight may be due to glycosylation, Western blots were performed after inhibition of N or O glycosylation. Tunicamycin treatment led to the appearance of an additional band of 66 kD, which was the dominating band in lysates of the C4.4A transfected lines. Inhibition of O-glycosylation had no eect on the molecular weight of PROG and the transfected lines. The molecular weight of Figure 1 Fluorescence analysis of COS-7 cells transfected with a tumor-derived cDNA library. The cDNA of a metastasizing rat colon carcinoma (RG) was transfected repeatedly into COS-7 cells by electroporation, enriching for the C4.4A by staining with the mAB C4.4 and FACSorting after each round of transfection. Staining of COS-7 cells with C4.4 (®rst antibody) and a PE-labeled anti-mouse IgG1 (second antibody) is shown. (a) non-transfected COS-7 cells, (b) COS-7 cells transfected with the RG-derived cDNA library, (c) COS-7 cells transfected with the third Hirt extract BSp73ASML was slightly reduced corresponding to the molecular weight of PROG (data not shown). Thus the C4.4A clearly is N-glycosylated. The apparently higher molecular weight as revealed by Western blotting after tunicamycin treatment may be a consequence of addition modi®cation or of the GPI anchor (see below), but is not due to dimerization, because the Mr of the molecule in immunoprecipitates after surface biotinylation is the same under reducing and nonreducing conditions (data not shown).
The C-terminal sequence of the C4.4A suggested that the molecule may be phosphatidyl inositol anchored (Moller, 1993; Moller et al., 1992) . This suggestion was strengthened by the observation of a high degree of Triton X-100 insolubility of C4.4A, which is characteristic for GPI anchored molecules (Moller et al., 1992; Behrendt et al., 1990; Hanada et al., 1995) (Figure 6a ). Distinct to D6.1A, a metastasisassociated, tetraspanin molecule, which also expressed on BSp73ASML, RG and PROG, the majority of the C4.4A was detected in the TritonX-100 insoluble fraction, even at a concentration of 1% Triton. As described for GPI anchored molecules Ko and Thompson, 1995) , C4.4A could, however, be solubilized by TritonX-114 and by TritonX-100 at 378C (data not shown). In contrast, distinct to other GPI-anchored molecules (Strohmeier et al., 1997) , C4.4.A was not solubilized by Octylglycosid ( Figure 6b ).
Other detergents as NP-40 or CHAPS were not capable to solubilize the TritonX-100 insoluble fraction. Disruption of the cytoskeleton by Cytochala- sin B had no in¯uence on the solubility of C4, 4A ( Figure 6b ). Furthermore, insolubility was also not caused by Ca 2+ -dependent protein-protein interactions, because the same results were obtained in the presence of EDTA (data not shown).
The GPI anchorage of C4.4A was ®nally proven by treatment with phosphatidyl-inositol phospholipase C (Moller, 1993; Plough et al., 1991) . As shown by Western blotting and by¯uorescence surface staining, C4.4A was removed from the cell membrane after phosphatidyl-inositol phospholipase C treatment (Figure 7 ).
C4.4 and metastasis formation
C4.4A originally has been detected only on rat tumor lines, which metastasize via the lymphatic system. Thus, it was of special interest, whether C4.4A would be involved in the process of tumor progression (Table  1) . To evaluate a possible in¯uence of C4.4A on tumorigenicity, the two C4.4A transfected BSp73AS lines, AS-1B1 and AS-2A2 were inoculated intravenously and survival time as well as metastasis formation were compared to mock-transfected cells. It became apparent that the survival time of all three groups was comparable and that all rats developed lung metastasis. However, while few and well encapsulated nodules were detected in rats receiving mock-transfected cells, distinct nodules were dicult to dissect in rats receiving AS-1B1 and AS-2A2 and the lung tissue was largely replaced by the tumor load. Histological sections of the lung con®rmed that AS-1B1 and AS-2A2 were not encapsulated at all (data not shown).
When mock transfected and C4.4A transfected BSp73AS cells were inoculated intrafootpad (Table  1) , and the tumor together with the draining (popliteal) lymph node were excised at 2 weeks after inoculation, animals became moribund after about 2 months. Five out of six rats which had received mock transfected BSp73AS cells had large tumor masses in the most proximal (inguinal) lymph node. Distant lymph nodes and the lung, with one exception were free of tumor cells. Both C4.4A transfected lines grew more slowly and removing the primary tumor burden at 2 weeks after transfer was curative for two and three out of ®ve rats, respectively. The remaining rats, where secondary tumor growth was noted, showed lung metastasis. However, only in two out of these ®ve rats tumor cells could be recovered from the most proximal one and distant lymph nodes were free of tumor cells in all ®ve rats. Instead, there was miliar dissemination of the tumor in the peritoneal cavity of three rats. To guarantee a higher rate of secondary tumor growth, the experiment was repeated and the primary tumor together with the draining lymph node was excised at 3 and 4 weeks after tumor cell application. When the primary tumor was excised at these later time points, eight out of nine and six out of six animals receiving mock transfected cells developed lymph node metastases and only three animals remained free of lung metastases. Lung metastases (mean: 10.0 and 11.3, respectively) were small and well encapsulated ( Figure  8a ). The number of lung metastases was slightly increased in rats receiving C4.4A transfected tumor cells (mean: 18.8 and 21.0, respectively). However, metastases in the lung were large and not encapsulated (Figure 8b ± 8d) . Because this particular pattern of metastasis formation was also seen when C4.4A cDNA was transfected in a ®brosarcoma line (BSp6S) ( Figure  8e ) or in a pheochromoblastoma line (BSp3A) (data not shown), we concluded that the incapability of matrix formation and/or the strong degradation of the ECM were an autonomous feature of C4.4A and independent of the epithelial or mesodermal origin of the tumor cell.
Thus, C4.4A did not suce to initiate metastatic spread, but facilitated metastasis formation.
Functional activity of C4.4A in substrate adhesion and matrigel penetration Phosphatidyl-inositol anchored molecules display a variety of functions (rev. in Moller, 1993; Anderson, 1994) , which could well be of importance in tumor progression, like the involvement in signal transduction, the capacity to support cell proliferation upon crosslinking and the participation in matrix degradation (Estreicher et al., 1990; Testa and Quigley, 1990; Andreasen et al., 1997; DeClerck and Laug, 1996) . Our studies did not reveal any linkage of C4.4A to phosphotyrosine kinases and cell proliferation was only in¯uenced to a minor degree by C4.4 (data not shown). But, ®rst experimental evidences, which are in line with the pattern of metastasis formation in vivo, supported the assumption that C4.4A might be involved in matrix degradation.
Our working hypothesis is based on the results of two experimental settings, adhesion to laminin and matrigel penetration. Expression of C4.4A, constitutively or via transfection, had no in¯uence on binding to hyaluronic acid, collagen I, III and IV, ®bronectin and vitronectin (data not shown). Instead, C4.4A + cells adhered strongly to laminin coated plates and binding was inhibited by C4.4 (Figure 9a ). To dierentiate between binding and adhesion, the experiment was done in parallel at 48C and 378C. Particularly BSp73ASML cells, but also BSp73AS-1B1 adhered more eciently at 378C (Figure 9b ). Our interpretation of active adhesion via C4.4A was strengthened by the ®nding that C4.4A + cells spread very rapidly on laminin coated plates, the phenomenon has not been observed on BSA or collagen coated plated (data not shown). Because BSp73ASML as well as BSp73AS cells express a6b1 and weakly a3 integrins (Claas et al., 1998) , we next asked, whether adhesion to laminin may be integrindependent. The ®nding that in the presence of EDTA adhesion of C4.4A + cells to laminin was weakened, but not abolished argues for laminin binding via C4.4A to be at least partly an integrin-independent process (Figure 9c) . Interestingly, as shown in Figure  9a , adhesion to laminin was transient, i.e. after 2 ± 4 h less C4.4A + cells adhered to laminin coated plates than after 30 min. In order to evaluate whether the transient nature of adhesion may be brought about by degradation of laminin, the protease inhibitor aprotinin was added to the culture medium. In the presence of aprotinin, adhesion to laminin remained stable over the observation period of 2 h (Figure 9d) .
The transient adhesion of C4.4A + cells to laminin strengthened our hypothesis that C4.4A may enable cells for degradation of elements of the extracellular matrix.
Indeed, when constitutively C4.4A + BSp73ASML cells were layered on matrigel coated transwell plates (Table 2) , 66% migrated through the matrix within 24 h. In the presence of C4.4 (10 mg/ml) migration through the matrix was nearly completely inhibited. However, only a minority of cells transfected with C4.4A + cDNA penetrated through the matrigel. One possible reason for the failure of C4.4A transfected BSp73AS cells to penetrate the matrigel could be the lack of C4.4A ligand expression, whereas on the constitutively C4.4A + line BSp73ASML uPA (Figure 10 ). Anti-uPAR bound to PROG, which line is known to be uPAR-positive (Durliat et al., 1992) (data not shown) and to BSp73ASML, but not to BSp73AS and BSp73AS-1B1. Thus, BSp73AS does not express the uPAR and anti-uPAR does not recognize C4.4A. However, uPA binds, albeit weakly, to C4.4A (Figure 11 ). In the ®rst setting binding of uPA to the C4.4A + and uPAR + line BSp73ASML, the C4.4A + line BSp73AS-1B1 and the uPAR 7 and C4.4A 7 line BSp73AS was evaluated. Where indicated, cells were acid pretreated to remove, as far as present, endogenous uPA. uPA did not bind to BSp73AS-mock cells, but did bind to BSp73AS-1B1 and BSp73ASML, although binding was weak. Thus, only metastasizing tumor lines of the rat (Claas et al., 1996) express a molecule with partial homology to the uPAR. Expression of the molecule has no in¯uence on initiation of the metastatic cascade, but facilitates metastasis formation, possibly by focalizing and activating extracellular matrix degrading enzymes. This feature is independent of the origin of tumor tissue and appears to be initiated by binding of uPA and/or, more likely, an uPA-related molecule to C4.4A.
Discussion
We here describe a metastasis-associated molecule, whose association to tumor progression was deduced from the observation that the monoclonal antibody C4.4 stained exclusively rat tumor lines which metastasize via the lymphatic system, but did not stain non-metastasizing tumor lines. Besides of its expression on metastasizing tumors C4.4A was detected only on very few selected epithelia. But, expression was upregulated on placental tissue (Claas et al., 1996) , which ®nding could well be in line with a potential role in tumor cell invasiveness (Khoka and Waterhouse, 1993) .
Cloning and sequencing of the molecule recognized by C4.4 revealed a low degree of homology to the uPAR of several species. Like the uPAR (Moller, 1993; Plough et al., 1991) , C4.4A is GPI anchored. The GPI anchorage of C4.4A was suggested by the detergent insolubility (Moller et al., 1992; Behrendt et al., 1990; Hanada et al., 1995) and was proven by the solubilization via PI-PLC (Moller, 1993; Plough et al., 1991) . However, C4.4A was missing some features frequently associated with GPI-anchored molecules: It could not be solubilized by Octylgycoside. Distinct to many GPI-anchored molecules (Hube and Altevogt, 1994 ; Shenoy-Scaria et al., 1992; Cook et al., 1992), ) m/m were suspended in medium containing either 10 mg/ml of a control IgG1 or 10 mg/ml C4.4 and were seeded on matrigel coated transwell plates. The number of cells in the lower chamber was counted after 48 h. Mean s.d of triplicate crosslinking of C4.4A had only a minor in¯uence on the proliferative activity of C4.4A expressing tumor cells (data not shown). GPI-anchored molecules are also described to be frequently linked to phosphotyrosine kinases (Malek et al., 1994; Morgan et al., 1993; Nazih-Sanderson et al., 1997; Resta and Thompson, 1997) . Again this was not the case with C4.4A (data not shown).
The most promising feature for unraveling the functional activity of this newly described GPI anchored molecule with homology to the uPAR relied on its metastasis-associated expression. By transfection of the cDNA into a low metastasizing tumor line it became apparent that C4.4A did not alter the metastatic potential of tumor cells, but in¯uenced the manner of host tissue invasion. Metastasis formation of C4.4A transfected lines was either miliary or at least without any form of encapsulation.
The assumption that C4.4A does not contribute to a major degree to the ®rst steps of the metastatic cascade was deduced from the observation that by excision of the primary tumor at 2 weeks after inoculation the incidence of lymph node and lung metastasis was rather reduced as compared to the parental line. Figure 9 In¯uence of C4.4A on cell proliferation and laminin binding. The tumor lines PROG, 73ASML, 73AS-mock and 73AS-1B1 were labeled with 51 Cr and were seeded (5610 4 cells/well) on BSA or laminin coated plates. Where indicated, the medium contained 10 mg/ml control IgG1 and C4.4, respectively. Cells were incubated for 30 ± 120 min. Non-adherent cells were washed o and, adherent cells were detached by trypsin treatment. Radioactivity was determined in a g-counter. Mean c.p.m.+s.d. of triplicate cultures are shown. (a) Cells were incubated in RPMI/5% FCS for 30 min and 120 min at 378C on BSA or laminin coated plates, the medium containing either 10 mg/ml control IgG1 or C4.4; (b) Cells were incubated for 30 min at 48C or at 378C; (c) Cells were seeded in RPMI/0.5% BSA, or in RPMI/0.5% BSA/1 mM EDTA and were incubated for 30 min at 378C; (d) Cells were seeded in RPMI/5% FCS or in RPMI/5% FCS containing 100 mg/ml aprotinin and were incubated for 30 min and 120 min at 378C However, the mode of metastasis formation diered between mock transfected and C4.4A transfected cells inasmuch as the number of lung metastases was slightly increased and, importantly, metastases amalgamated, had no or poor encapsulation and occasionally presented themselves in miliary form in the peritoneal cavity. In view of these observations it became likely that C4.4A is involved in the destruction of the extracellular matrix and possibly of endothelial cells/ capillary and lymphatic vessel walls, too. C4.4A transfected tumor cells share with the parental BSp73ASML line the features of miliary metastasis formation and the failure to build up a surrounding stroma layer. However, BSp73ASML cells metastasize within 1 week after tumor cell application, they very rapidly colonize the lymphatic tissue and form exclusively miliary metastases (Matzku et al., 1983) . Thus, transfection with C4.4A only partially restored the phenotype of BSp73ASML cells. The pattern of metastasis formation by C4.4A transfected tumor cells and the partial homology to the uPAR deserve some discussion. The uPAR has been shown to be of major relevance for tumor progression by targeting via uPA plasminogen to the cell surface, thus (i) preventing rapid degradation of the proenzyme and (ii) facilitating high local concentrations of this matrix degrading enzyme (Moller, 1993; Testa and Quigley, 1990; Andreasen et al., 1997; DeClerck and Laug, 1996) . In fact, we could demonstrate that C4.4A expressing tumor cells bound transiently to laminin, a feature known to be associated with the uPA system (Schlechte and Boyd, 1990; Sordat and Tran-Thang, 1995) . Furthermore, but distinct to C4.4A cDNA transfected cells, constitutively C4.4A + lines very eciently penetrated a matrigel and this penetration was inhibited by C4.4. Considering the transient nature of binding to laminin, it could well be that by binding proteolytic enzymes became activated, which resulted in the degradation of laminin accompanied by detachment of the tumor cells. The ®nding that adhesion to laminin persisted in the presence of aprotinin supports our interpretation. Penetration of constitutively C4.4A + cells through matrigel and inhibition of this process by C4.4 is well in line with the assumption. C4.4A cDNA transfected BSp73AS cells, instead, hardly penetrated through the matrigel, although the pattern of transient adhesion to laminin and inhibition of adhesion by C4.4 were similar. Thus, we assume that BSp73AS cells provide directly or indirectly enzymes which allow selectively for laminin degradation, whereas BSp73ASML cells might express in addition enzymes/enzyme activators which function in concert with C4.4A to destruct additional components of the extracellular matrix. One possible candidate would be uPA, which we showed to bind, albeit weakly, to C4.4A. Because of the weakness of this interaction we consider it as likely that there exist additional and more speci®c ligands for C4.4A. Furthermore, it should be noted that binding of uPA to the uPAR-and C4.4A-positive line BSp73ASML was signi®cantly increased after acid pretreatment of the cells to remove endogenously bound uPA. This was not the case with the C4.4A cDNA transfected BSp73AS line. The ®nding is well in line with our assumption that BSp73ASML cells dispose of a more complete set of matrix degrading enzymes than C4.4A transfected BSp73AS cells, i.e. that the uPAR and the C4.4A on BSp73ASML cells are occupied by uPA and/or the not yet de®ned proper ligand of C4.4A. Finally, as also described for the uPAR, it could well be that C4.4A transfected BSp73AS cells can recruit in vivo uPA and/ or related molecules from host cells (Dimanche-Boitrel et al., 1994) . Taking into account this possibility it becomes comprehensible that C4.4A transfected cells degrade in vivo eciently surrounding tissue, but hardly a layer of matrigel in vitro. In addition, focalization or conformational changes of the uPAR have been described to be of importance considering its functional activity (Suh et al., 1994; Jardi et al., 1996) . This may also account for C4.4A and will be taken into consideration in further pursuing the functional activity of C4.4A.
In summary, we have isolated a new GPI anchored molecules from a metastasizing tumor line, which structurally and functionally displays similarities to the uPAR and facilitates embedding of metastasizing tumor cells likely by degradation of the extracellular matrix. Taking into account that there is ample evidence for the important of metalloproteinases and the plasminogen system in metastasis formation (Mareel et al., 1993; Stetler-Stevenons et al., 1993; Moller, 1993; DeClerck and Laug, 1996; Fazioli and Blasi, 1994; Andreasen et al., 1997; Testa and Quigley, 1990; Nagase, 1997; Crawford and Matrisian, 1995) and that much eort is put into trials to prevent activation of these enzymes as a therapeutic regimen (Fazioli and Blasi, 1994; Burgle et al., 1997; Crowley et al., 1993) , an interference with metastasis formation by blockade of the C4.4A molecule appears quite promising. Such an approach would also pro®t from the fact that expression of the C4.4A molecule in the adult is very restricted. Experiments to isolate and characterize the human homologue of C4.4A are in progress.
Materials and methods

Animals and tumors
BDX rats were obtained from Charles River, Sulzfeld, Germany. They were kept under SPF conditions, fed with conventional diet and water at libitum. They were used for experiments at the age of 8 ± 10 weeks.
The following tumor lines were used: BSP73ASML (metastasizing pancreatic adenocarcinoma) and BSp73AS (low-metastasizing pancreatic adenocarcinoma) (Matzku et al., 1983) , BSp6S (subline of a non-metastasizing fibrosarcoma) and BSp3A (subline of a non-metastasizing pheochromoblastoma) (ZoÈ ller et al., 1978) . BSp73AS-C4.4A (BSp73A transfected with cDNA coding for the C4.4A molecules) and BSp73AS-mock (BSp73AS transfected with the pCDNA3-vector) are described below. All these tumor lines were derived from the BDX rat strain. The tumor lines regressor (RG) and progressor (PROG), a metastasizing colon carcinoma of the BDIX strain, has been kindly provided by F Martin (Reisser et al., 1993) . The adherently growing tumor lines were cultured in RPMI 1640 supplemented with 10% fetal calf serum (FCS). Con¯uent cultures were either trypsinized (BSp73ASML, PROG and RG) or treated with EDTA (BSp73AS, BSp6S, BSp3A) and split. COS-7 cells were obtained from the ATCC. They were cultured in DMEM supplemented with 10% fetal calf serum.
Antibodies
The mAB C4.4 (mouse IgG1) and an isotype matched control antibody, 3 ± 9, binding a Ga-chelate complex have been described previously (Matzku et al., 1989; ZoÈ ller et al., 1992) ; A rabbit anti-rat uPAR was obtained from American Diagnostics. Polyclonal rabbit anti-mouse IgG1 and¯uorescence dye labeled derivatives as well as an FITC labeled anti-rat IgG were obtained from Southern Biotechnology (Birmingham, AL). For FACS analysis cells were harvested, washed and resuspended at 5610 5 cells/50 ml PBS containing 2% FCS. Cells were incubated with the ®rst antibody (10mg/ml) for 30 min at 48C and after washing with the second, dye-labeled antibody (30 min at 48C) at appropriate dilutions. After washing again,¯uorescence staining was evaluated using an EPICS XL (Coulter Hialeah, FL).
cDNA library and selection of clones coding for the surface molecule C4.4A mRNA was prepared from the colon carcinoma cell line RG and oligo(dT)/Not primed cDNA was prepared using the Librarian Kit (Invitrogen, San Diego). The cDNA was inserted unidirectional into the mammalian expression vector pcDNA3 after ligation of BstXI adaptors and cleavage with Notl. The ligated DNA was transformed into E. coli/TOP10F'. After cultivation, isolation of the plasmid DNA and plating of aliquots, the size of the library was estimated to about 2610 7 clones. For the isolation of clones coding for the metastasisassociated surface molecule C4.4A, 15 mg of the cDNA was transfected into COS-7 cells by electroporation. After 3 days cells were stained with the mAB C4.4 and a PE-coupled goat anti-mouse IgG. Strongly stained cells were isolated bȳ uorescence activated cell sorting using a FACStar (Becton Dickinson, Mountain View, CA). Plasmid DNA of the stained cells was isolated by lysis according to the method described by Hirt (1967) . Genomic DNA and proteins were separated by centrifugation. The plasmid DNA/RNA mixture was digested with RNase A (20 mg/ml) and Proteinase K (50 mg/ml), followed by a phenol-chloroform extraction to remove residual protein. The remaining plasmid DNA was precipitated and used for the transformation of E. coli by electroporation. The procedure was repeated three times. Thereafter the plasmid DNA was isolated from single bacterial colonies and was used for DEAE transfection of COS-7 cells. After 3 days cells were analysed for antigen expression by FACS. The cDNA of positive clones was sequenced according to the method of Sanger et al. (1977) .
Transfection of COS-7 cells and C4.4A-negative tumor lines with C4.4A-cDNA
The tumor lines BSp73AS, BSp6S and BSp3A were harvested during growth in log phase. Cells (1610 7 /ml) were resuspended in RPMI 1640 containing 10% FCS and were mixed with 15 mg of the pcDNA3-C4.4A plasmid in a sterile cuvette. Electroporation was performed after 5 min incubation at room temperature at 260 V and 1050 mF using a Bio-Rad Genepulser with capacitance extender. Transfected cells were selected by growth in RPMI 1640 containing 10% FCS and 500 mg/ml G418. G418 resistant cells were analysed for C4.4A expression by¯owcytometry and were recloned.
PCR
Total RNA was extracted by the guanidine isothiocyanate/ acid phenol method of Chomczynski and Sacchi (1987) . cDNA was synthesized and subjected to PCR ampli®cation using 2 mg total RNA and 1 mg oligo (dT) 15 for synthesis of the ®rst strand and C4.4A-speci®c primers for the ampli®cation. The following C4.4A speci®c oligonucleotides were used: 5' TGCTACAGCTGCGTGCAA and 3': TTGGAACTGCGGATGCTG. Ampli®cation was performed at 598C with 5' and 3' oligos for 35 cycles. Ampli®cation of GAPDH was performed accordingly at 538C. PCR products were analysed on a 1% agarose gel.
SDS ± PAGE and Western blot
SDS ± PAGE was performed under non-reducing conditions using 8 or 10% gels according to the method of Laemmli (1970) . Gels were transferred to PVDF membranes (Millipore) by the method of Towbin et al. (1979) . Membranes were blocked by incubation in PBS containing 5% (w/v) non-fat dry milk powder and 0.1% (v/v) Tween 20 for 1 h at room temperature. After incubation for 1 h with the appropriate ®rst antibody, membranes were washed four times with PBS/0.1% Tween 20, incubated for 1 h with goat anti-mouse IgG1-horseradish peroxidase (HRPO) (1/5000 in PBS/0.1% Tween 20) and washed four times with PBS/0.1% Tween 20. Detection was performed by the enhanced chemiluminescence assay according to the manufacturer's protocol (Amersham, Braunschweig, Germany).
Anchorage, glycosylation and solubility N-and O-glycosylation were inhibited by plating 2610 5 cells (six well plate) and growing the cells in RPMI 1640, 10% FCS containing either 2.5 mg/ml Tunicamycin (Elbein, 1984) or 2 mM phenyl-!-GalNac (Dasgupta et al., 1996) . Thereafter cells were harvested, suspended in 300 ml SDS sample buer (3 ml glycerol, 1 g SDS, 1.2 mg bromphenol blue, 7 ml 0.5 M Tris-HCl, 0.4% SDS, pH 6.8) and analysed by Western blot. To determine detergent solubility cells growing in log phase were harvested, washed with PBS and resuspended in 100 ml of extraction buer (10 mM Tris-HCl, pH 7.4, 150 mM NaCl, 1 mM MgCl 2 , 1 mM CaCl 2 , 0.5 mM PMSF) containing the following detergents: 0.5% and 1% Triton X-100, NP-40, CHAPS and 60 mM Octyl glucoside (Melkonian et al., 1995) . Insoluble material was collected by centrifugation for 2 min at 12 000 r.p.m. in a Heraeus Biofuge 13R at 48C. The supernatant containing the detergent-soluble proteins was removed and mixed with 1/6 volume of 66 SDS sample buer. The pelleted material was washed once with 500 ml extraction buer and resuspended in 100 ml of 16 SDS sample buer. DNA was shared by soni®cation. Membrane anchorage was determined by GPI-PLC treatment (Ferguson and Williams, 1988) . 5610 6 C4.4A-transfected and untransfected AS cells were harvested, washed twice with PBS and resuspended in 100 ml PBS containing 1 mM MgCl 2 . After incubation for 1 h with 0.25U Phosphatidyl-inositol (GPI)-speci®c phospholipase C (Boehringer Mannheim) at 378C, cells were analysed by Western blot and¯ow cytometry.
Adhesion, migration and proliferation assays
In adhesion studies cells were labeled with 51 Cr and were seeded either on a monolayer of adherent cells or on plates coated with components of the extracellular matrix, i.e. hyaluronic acid (HA), collagen type I, type III and type IV, laminin (LA), ®bronectin and vitronectin. The components of the extracellular matrix, except for HA were coated at 10 mg/ml; HA was coated at a concentration of 100 mg/ml. To dierentiate between binding and adhesion, the assay was run at 48C and 378C. Dependence on integrin interactions was explored by addition of 1 mM EDTA. The protease inhibitor aprotinin (100 mg/ml) was added to exclude laminin degradation. Where indicated, anti-C4.4 (10 mg/ml) was added to the culture medium. Cells were incubated for 30 min to 2 h and were washed repeatedly. The adherent cells were lysed by 2% SDS, transferred into counting vials and counted in a g-counter. The percentage of adherent cells is shown.
The migratory activity of C4.4A + cells was evaluated in a matrigel assay. Membranes with a pore size of 8 mm were coated with 50 ml matrigel (Sigma, St Louis, MO, USA). The membranes were inserted into 24 well plates which contained medium without supplements. Tumor cells (1610 4 ) were suspended in RPMI 1640 supplemented with 10% FCS and, where indicated, with 10 mg/ml C4.4 and were seeded on the matrigel. Plates were incubated for 48 h at 378C. Thereafter cells at the bottom of the chamber were counted using an inverted microscope.
Proliferation of C4.4A transfected cells was tested by [ 
Rat uPA binding studies
Rat uPA (American Diagnostics) was labeled with 125 I by the procedure described by Fraker and Speck (1978) . Brie¯y, 5 mg of uPA in 100 ml Na-phosphate buer, pH 7.4 were incubated for 5 min with 100 mCi Na [
125 I] in iodogen-coated tubes. After addition of 400 ml 0.05 M Naphosphate, the labeled uPA was separated from the free 125 I by passage over a NAP-5 column (Pharmacia) according to the manufacturer's instructions. Binding studies were performed according to the method described by Schlechte et al. (1989) . In brief: C4.4A + tumor cells (5610 4 ) were seeded on¯at bottom 96 well plates and were incubated overnight. Cells were washed with PBS to remove FCS and, where indicated, were acid pretreated for 3 min (glycine 50 mM, 0.1 M NaCl, pH 3.0) to remove bound uPA. The pH was restored by a solution containing 0.5 M HEPES, 0.1 M NaCl, pH 7.4. 125 I-labeled uPA was diluted in binding buer (20 mM HEPES, 0.1% BSA in RPMI 1640, pH 7.4) and seeded on the adherent tumor cell layer (starting with 2610 6 c.p.m./well). Plates were incubated for 30 min at 378C. In a parallel setting, test samples contained, in addition, either 10 mg/ml 3 ± 9 (control IgG1) or C4.4 or anti-uPAR or a 20-fold excess of unlabeled uPA. Plates were washed three times, cells were lysed in 2% SDS, the lysate was transferred to counting vials and bound radioactivity was determined in a g-counter.
Metastasis assay BDX rats received 5610 5 tumor cells, i.v. or i.f.p.. In the latter case the tumor and the draining lymph node were excised by amputation in the knee as soon as the primary tumor reached a diameter of 0.5 cm. Animals were observed for local tumor growth, weight loss, anemia and shortage of breathing. They were sacri®ced before reaching a moribund stage. Metastasis formation was controlled macroscopically and by histology.
Statistics
Signi®cance of dierences was calculated by the two tailed Student's t test.
Abbreviations AA: amino acid, i.f.p.: intrafootpad, LA: laminin, mAB: monoclonal antibody, GPI: glycosylphosphatidyl-inositol, HRPO: horseradish peroxidase, PROG: progressor, RG: regressor, uPA: urokinase plasminogen activator, uPAR: uPA receptor.
